Covid-19 vaccine Covaxin
Covid-19 vaccine update, corona vaccine covaxin, corona vaccine status all we about on this page.
The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human medical trial of the indigenously developed Covid-19 vaccine candidate Covaxin. The hospital will begin enrolling wholesome people from today onwards, news Agency PTI had reported.
“Few volunteers have already registered for the trial. We would start the screening of the individuals and evaluate their health condition from Monday onwards before vaccinating them,” Dr Sanjay Rai, Professor on the Centre for Community Medicine at AIIMS had mentioned.
12 sites selected for phase I and II human trials of Covid-19 vaccine update: Covaxin
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting part I and II human trials of Covaxin. In part I, the vaccine could be examined on 375 volunteers and the maximum of 100 of them would be from AIIMS.
Volunteers wanted for clinical trial of Covid-19 vaccine Covaxin in AIIMS Delhi
- Healthy volunteers having no comorbid conditions and with no history of COVID-19, aged more than 18 years and less than 55 years, could be eligible to take part in the randomised, double-blind, placebo-controlled clinical trial.
- Anybody willing to take part in the trial can send an email to Ctaiims.firstname.lastname@example.org or an SMS to or call on 7428847499
- The institute can also put up these contact details on its web site.
India’s first indigenous Covid-19 vaccine candidate Covaxin is being developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV).
Covid-19 vaccine Covaxin trial begins
The trials have up to now began in AIIMS, Patna and some more sites. AIIMS Patna was the primary institute to begin the trial on Wednesday and has up to now vaccinated around 9 people with a smaller dose to examine for security, two sources mentioned, on situation of anonymity.
India’s Covid-19 vaccine update
The DCGI has permitted two vaccines, one developed by the Bharat Biotech International Limited in collaboration with the ICMR and one other one by Zydas Cadila Healthcare Ltd to go in for part I and II human clinical trials.
Approximately 1,000 human volunteers could be taking part in the exercise for every of the 2 indigenous developed vaccine candidates. India is one of the largest Covid-19 vaccine producers in the world.